SAN ANTONIO — An asthma risk questionnaire was effective in predicting exacerbations for patients over both short and long terms, data presented at the American Academy of Allergy, Asthma & Immunology Annual Meeting showed.
William McCann, MD, FAAAAI, vice president and chief medical officer of Allergy Partners, told Healio that initial results from the Asthma Impairment and Risk Questionnaire, or AIRQ, showed that the tool was very strong at indicating risk levels for future exacerbations over the next year.
“So, patients who were more poorly controlled were more prone to have